TG-IGF1R: A Novel Receptor Tyrosine Kinase Fusion Oncogene in Pediatric Thyroid Cancer
0
Authors
Julio Ricarte‐Filho
Julio Ricarte‐Filho•Erin Reichenberger•Aime Franco
Published
August 6, 2024
Abstract
Receptor Tyrosine Kinase (RTK) fusions of RET, NTRK1/3, and ALK are enriched among pediatric thyroid cancer patients with metastatic and persistent disease and their oncoproteins represent attractive drug targets.
